Anjana Menon

Amrita Institute of Medical Sciences and Research Centre — India

Medicine · Health Sciences

8h-index1.9kcitations31works1.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Prostate Cancer Treatment and Research(21), Radiopharmaceutical Chemistry and Applications(11), Prostate Cancer Diagnosis and Treatment(6), Cancer, Lipids, and Metabolism(5), Advanced Proteomics Techniques and Applications(3)

Publications31 total

Linking necroptosis with liver aging and chronic inflammation in hepatic pathology
Life Sciences·2025· 3 cited
Modulating the JAK/STAT pathway with natural products: potential and challenges in cancer therapy
Discover Oncology·2025· 3 citedOpen Access
Race-based differences in serum biomarkers for cancer-associated cachexia in a diverse cohort of patients with pancreatic ductal adenocarcinoma
2025Open Access
Chimeric Antigen Receptor (CAR) - T Cells Based Cancer Immunotherapy: Harnessing the Potential of Nanobiotechnology
2024
Supplementary Figure 1 from Characterization of <i>TMPRSS2</i>-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
2023Open Access
Data from A Fluorescence <i>In situ</i> Hybridization Screen for E26 Transformation–Specific Aberrations: Identification of DDX5-ETV4 Fusion Protein in Prostate Cancer
2023Open Access
Supplementary Table 2 from Characterization of <i>TMPRSS2</i>-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
2023Open Access
Data from Characterization of <i>TMPRSS2</i>-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
2023Open Access
Supplementary Table 1, Figures 1-3 from A Fluorescence <i>In situ</i> Hybridization Screen for E26 Transformation–Specific Aberrations: Identification of DDX5-ETV4 Fusion Protein in Prostate Cancer
2023Open Access
Supplementary Information from Characterization of <i>TMPRSS2</i>-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
2023Open Access
Supplementary Table 1, Figures 1-3 from A Fluorescence <i>In situ</i> Hybridization Screen for E26 Transformation–Specific Aberrations: Identification of DDX5-ETV4 Fusion Protein in Prostate Cancer
2023Open Access
Supplementary Table 2 from Characterization of <i>TMPRSS2</i>-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
2023Open Access
Supplementary Table 1 from Characterization of <i>TMPRSS2</i>-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
2023Open Access
Supplementary Table 1 from Characterization of <i>TMPRSS2</i>-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
2023Open Access
Data from A Fluorescence <i>In situ</i> Hybridization Screen for E26 Transformation–Specific Aberrations: Identification of DDX5-ETV4 Fusion Protein in Prostate Cancer
2023Open Access
Supplementary Figure 1 from Characterization of <i>TMPRSS2</i>-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
2023Open Access
Data from Characterization of <i>TMPRSS2</i>-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
2023Open Access
Supplementary Information from Characterization of <i>TMPRSS2</i>-ETS Gene Aberrations in Androgen-Independent Metastatic Prostate Cancer
2023Open Access
Intelligent Water Distribution and Monitoring System
2021· 8 cited
Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression
Modern Pathology·2009· 228 citedOpen Access
page 1 of 2Next →

Frequent Co-authors

Scott A. Tomlins(24), Rajal B. Shah(23), Rohit Mehra(23), Arul M. Chinnaiyan(21), Mark A. Rubin(16), Kenneth J. Pienta(16), Xuhong Cao(15), Bharathi Laxman(11), Lei Wang(11), Saravana M. Dhanasekaran(10), Jianjun Yu(10), Sooryanarayana Varambally(9), Robert J. Lonigro(6), Nallasivam Palanisamy(6), Chandan Kumar‐Sinha(6), Bo Han(5), Jindan Yu(5), James E. Montie(5), Arul M. Chinnaiyan(5), Yusong Gong(5)